204 related articles for article (PubMed ID: 9292514)
1. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice.
Shivdasani RA; Fielder P; Keller GA; Orkin SH; de Sauvage FJ
Blood; 1997 Sep; 90(5):1821-7. PubMed ID: 9292514
[TBL] [Abstract][Full Text] [Related]
2. Consequences of GATA-1 deficiency in megakaryocytes and platelets.
Vyas P; Ault K; Jackson CW; Orkin SH; Shivdasani RA
Blood; 1999 May; 93(9):2867-75. PubMed ID: 10216081
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.
Shivdasani RA; Rosenblatt MF; Zucker-Franklin D; Jackson CW; Hunt P; Saris CJ; Orkin SH
Cell; 1995 Jun; 81(5):695-704. PubMed ID: 7774011
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
[TBL] [Abstract][Full Text] [Related]
6. Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice.
Chang M; Qian JX; Lee SM; Joubran J; Fernandez G; Nichols J; Knoppel A; Buzby JS
Blood; 1999 Apr; 93(8):2515-24. PubMed ID: 10194430
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells.
Nagata Y; Nagahisa H; Aida Y; Okutomi K; Nagasawa T; Todokoro K
J Biol Chem; 1995 Aug; 270(34):19673-5. PubMed ID: 7649975
[TBL] [Abstract][Full Text] [Related]
8. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells.
Chuen CK; Li K; Yang M; Fok TF; Li CK; Chui CM; Yuen PM
J Lab Clin Med; 2004 Feb; 143(2):75-88. PubMed ID: 14966463
[TBL] [Abstract][Full Text] [Related]
10. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.
Fielder PJ; Gurney AL; Stefanich E; Marian M; Moore MW; Carver-Moore K; de Sauvage FJ
Blood; 1996 Mar; 87(6):2154-61. PubMed ID: 8630374
[TBL] [Abstract][Full Text] [Related]
11. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
[TBL] [Abstract][Full Text] [Related]
12. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes.
Lecine P; Villeval JL; Vyas P; Swencki B; Xu Y; Shivdasani RA
Blood; 1998 Sep; 92(5):1608-16. PubMed ID: 9716588
[TBL] [Abstract][Full Text] [Related]
13. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.
Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y
Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2.
Levin J; Peng JP; Baker GR; Villeval JL; Lecine P; Burstein SA; Shivdasani RA
Blood; 1999 Nov; 94(9):3037-47. PubMed ID: 10556187
[TBL] [Abstract][Full Text] [Related]
15. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
16. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.
Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ
Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234
[TBL] [Abstract][Full Text] [Related]
17. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
Murone M; Carpenter DA; de Sauvage FJ
Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
20. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.
Hou M; Andersson PO; Stockelberg D; Mellqvist UH; Ridell B; Wadenvik H
Br J Haematol; 1998 Jun; 101(3):420-4. PubMed ID: 9633881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
